160 related articles for article (PubMed ID: 29446085)
1. DR4 mediates the progression, invasion, metastasis and survival of colorectal cancer through the Sp1/NF1 switch axis on genomic locus.
Wu S; Meng Q; Zhang C; Sun H; Lu R; Gao N; Yang H; Li X; Aschner M; Chen R
Int J Cancer; 2018 Jul; 143(2):289-297. PubMed ID: 29446085
[TBL] [Abstract][Full Text] [Related]
2. [Associations of Crohn's disease with DR4 and DR5 gene polymorphisms].
Lin X; Jin L; Pan C; Zheng S; Zhang D; Lin X; Ding R; Jiang L; Jiang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct; 32(5):715-22. PubMed ID: 26418999
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR4) genes contribute to susceptibility to colorectal cancer in pakistani population.
Zahoor A; Mansoor Q; Farooqi AA; Fayyaz S; Naz G; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):108-12. PubMed ID: 26518902
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.
Sarwar R; Mansoor Q; Farooqi AA; Shahzad S; Fayyaz S; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):53-6. PubMed ID: 26718429
[TBL] [Abstract][Full Text] [Related]
5. Association between polymorphism in the promoter region of lncRNA GAS5 and the risk of colorectal cancer.
Wang Y; Wu S; Yang X; Li X; Chen R
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30902880
[TBL] [Abstract][Full Text] [Related]
6. FAS rs2234767 and rs1800682 polymorphisms jointly contributed to risk of colorectal cancer by affecting SP1/STAT1 complex recruitment to chromatin.
Wang S; Wu S; Meng Q; Li X; Zhang J; Chen R; Wang M
Sci Rep; 2016 Jan; 6():19229. PubMed ID: 26759270
[TBL] [Abstract][Full Text] [Related]
7. TNFRSF10A-LOC389641 rs13278062 but not REST-C4orf14-POLR2B-IGFBP7 rs1713985 was found associated with age-related macular degeneration in a Chinese population.
Sun Y; Li S; Li H; Yang F; Bai Y; Zhao M; Guo J; Zhao M; Zhou P; Khor CC; Huang L; Li X
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8199-203. PubMed ID: 24235014
[TBL] [Abstract][Full Text] [Related]
8. MALAT1 rs664589 Polymorphism Inhibits Binding to miR-194-5p, Contributing to Colorectal Cancer Risk, Growth, and Metastasis.
Wu S; Sun H; Wang Y; Yang X; Meng Q; Yang H; Zhu H; Tang W; Li X; Aschner M; Chen R
Cancer Res; 2019 Oct; 79(20):5432-5441. PubMed ID: 31311811
[TBL] [Abstract][Full Text] [Related]
9. Regulation of TRAIL receptor expression by β-catenin in colorectal tumours.
Jalving M; Heijink DM; Koornstra JJ; Boersma-van Ek W; Zwart N; Wesseling J; Sluiter WJ; de Vries EG; Kleibeuker JH; de Jong S
Carcinogenesis; 2014 May; 35(5):1092-9. PubMed ID: 24379239
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.
Timirci-Kahraman O; Ozkan NE; Turan S; Farooqi AA; Verim L; Ozturk T; Inal-Gultekin G; Isbir T; Ozturk O; Yaylim I
Genet Test Mol Biomarkers; 2015 Jun; 19(6):309-15. PubMed ID: 25955868
[TBL] [Abstract][Full Text] [Related]
11.
Meng Q; Wu S; Wang Y; Xu J; Sun H; Lu R; Gao N; Yang H; Li X; Tang B; Aschner M; Chen R
Cancer Res; 2018 May; 78(10):2760-2769. PubMed ID: 29540402
[TBL] [Abstract][Full Text] [Related]
12. MAGI2-AS3 rs7783388 polymorphism contributes to colorectal cancer risk through altering the binding affinity of the transcription factor GR to the MAGI2-AS3 promoter.
Yang X; Wu S; Li X; Yin Y; Chen R
J Clin Lab Anal; 2020 Oct; 34(10):e23431. PubMed ID: 32533587
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-22 suppresses the growth, migration and invasion of colorectal cancer cells through a Sp1 negative feedback loop.
Xia SS; Zhang GJ; Liu ZL; Tian HP; He Y; Meng CY; Li LF; Wang ZW; Zhou T
Oncotarget; 2017 May; 8(22):36266-36278. PubMed ID: 28422727
[TBL] [Abstract][Full Text] [Related]
14. SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer.
Yu Y; Peng K; Li H; Zhuang R; Wang Y; Li W; Yu S; Liang L; Xu X; Liu T
Oncol Rep; 2018 May; 39(5):2235-2242. PubMed ID: 29565456
[TBL] [Abstract][Full Text] [Related]
15. Death receptor 4 variants and colorectal cancer risk.
Frank B; Shanmugam KS; Beckmann L; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):2002-5. PubMed ID: 17035413
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 1B1 promotes cancer cell survival via specificity protein 1 (Sp1)-mediated suppression of death receptor 4.
Kwon YJ; Cho NH; Ye DJ; Baek HS; Ryu YS; Chun YJ
J Toxicol Environ Health A; 2018; 81(9):278-287. PubMed ID: 29473798
[TBL] [Abstract][Full Text] [Related]
17. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
18. Methylation of
Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
[TBL] [Abstract][Full Text] [Related]
19. Capsaicin sensitizes TRAIL-induced apoptosis through Sp1-mediated DR5 up-regulation: involvement of Ca(2+) influx.
Moon DO; Kang CH; Kang SH; Choi YH; Hyun JW; Chang WY; Kang HK; Koh YS; Maeng YH; Kim YR; Kim GY
Toxicol Appl Pharmacol; 2012 Feb; 259(1):87-95. PubMed ID: 22200406
[TBL] [Abstract][Full Text] [Related]
20. Death receptor 4 variants enhanced prostate cancer risk in North Indian population.
Mittal RD; Mandal RK; Singh A; Srivastava P
Tumour Biol; 2015 Jul; 36(7):5655-61. PubMed ID: 25691252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
